2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(propylamino)propyl]butanamide

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(propylamino)propyl]butanamide
• 化学式: C₁₂H₂₄N₂O₄
• 分子量: 260.33
• InChiKey: QACSALMWBOZZLM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  18
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  98.7
• 氢给体数：
  4
• 氢受体数：
  4

文献信息

• [EN] ORGANOSELENIUM COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS D'ORGANOSÉLÉNIUM ET LEURS UTILISATIONS
  申请人：ALQUEST THERAPEUTICS INC

  公开号：WO2011069002A1

  公开（公告）日：2011-06-09

  Provided herein are organoselenium compounds and pharmaceutical compositions thereof. Also provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders using the compounds and pharmaceutical compositions provided herein. reactive oxygen and nitrogen species

  本文提供了有机硒化合物及其制药组合物。本文还提供了使用所述化合物和制药组合物治疗、预防或改善各种医学疾病的方法。活性氧和氮物种。
• ORGANOSELENIUM COMPOUNDS AND USES THEREOF
  申请人：Erlanson Daniel A.

  公开号：US20110301235A1

  公开（公告）日：2011-12-08

  Provided herein are organoselenium compounds and pharmaceutical compositions thereof. Also provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders using the compounds and pharmaceutical compositions provided herein.
• METFORMIN DERIVATIVES
  申请人：BioPharma Works LLC

  公开号：US20170247400A1

  公开（公告）日：2017-08-31

  The present invention relates to novel biguanide derivatives including their pharmaceutically acceptable salts. The invention also relates processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions containing and the uses of such compounds in treating disorders such as diabetes.